Ahmed, I. O., Owojuyigbe, T., Olarewaju, O. J., Omoyiola, O., Oguns, O., Agim, M., Bamiteko, O., Fabinu, T., Umar, A., Ogunkoya, O., Bolarinwa, R. A., Durosinmi, M. A. (2026). Real-world experience with second and third generation tyrosine kinase inhibitors in imatinib-resistant Nigerian patients with BCR::ABL1 positive chronic myeloid leukaemia.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.19_suppl.255